Global Therapy Monitors
For today’s leading pharma and biotech companies, Global Therapy Monitors needs no introduction. We’ve been delivering real-world patient data, layered with HCP perceptions, for over 30 years – guiding decisions big and small across the product lifecycle.
We pride ourselves on the quality, reach and global comparability of our data – but it’s how we activate it that sets us apart…
Each Global Therapy Monitor subscription comes with the benefits and cost efficiencies of multi-client research, but with bespoke analyses and recommendations from experts in that disease – all tailored to your business questions and strategy.
About Global Therapy Monitors:
• Real-world patient treatment data layered with HCP perceptions
• Data trended wave on wave over years & decades (30+ years in some diseases)
• Operational excellence and a globally consistent methodology
• Bespoke analysis & recommendations from therapy area experts
• A reduced compliance burden due to the independence of datasets
• Insights applicable for myriad business questions & multiple client teams.
Diseases covered
Global Therapy Monitors run in oncology, obesity & cardiometabolic diseases, virology & vaccines, immunology, neurology and rare diseases.
Recent thought leadership
PoV: Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
Clinical Poster (UEGW 2025): Exploring the characteristics of treated Ulcerative Colitis (UC) patients with Mayo Endoscopic Subscore (MES) > 1
Clinical Poster (AAIC 2025): Understanding public willingness to undergo blood testing for Alzheimer’s Disease diagnosis
Data Insights: Empowered Consumers Lead The Obesity Market
Poster (EHA 2024): The Evolving Landscape of Haemophilia A Treatments
Connect with our therapy experts today.
